|Synonyms:||N-phenylacetyl-L-prolylglycine ethyl ester, GVS-111|
|Molecular Weight:||318.373 g/mol|
|Storage:||Store in a dry, dark, sealed container at room temperature.|
|Stability:||Stable at least for 2 years when stored probably.|
Noopept (GVS-111) is a compound with neuroprotective and cognition enhancing properties that is derived from the racetam family. It is used in neuroscience studies and in research related to protection against cognitive impairment. Animal studies have shown Noopept to be neuroprotective and enhance memory in various tests.
Its synthesis was first reported in 1996. It is orally available, and as of 2017 its metabolism and elimination half-life were not well understood, as cycloprolylglycine had not been measured in humans following administration.
As of 2017 there had been many studies conducted in cells and in animal models, and there had been one clinical trial with 41 subjects, which compared Noopept and 2-(2-oxopyrrolidin-1-yl)acetamide in people with traumatic brain injury.